Ebola is a deadly hemorrhagic disease caused by a virus that is endemic in parts of East-Central and West Africa. Most people are aware that a primary route for person-to-person transmission is ...
Q-901 is under clinical development by Qurient and currently in Phase II for Metastatic Pancreatic Cancer. According to GlobalData, Phase II drugs for Metastatic Pancreatic Cancer have a 31% phase ...
Telacebec is under clinical development by Qurient and currently in Phase II for Buruli Ulcer. According to GlobalData, Phase II drugs for Buruli Ulcer does not have sufficient historical data to ...